Senate Finance Committee Conducts Hearing about Issues Impacting Cost and Coverage in Health Care
September 12, 2017
Today, the U.S. Senate Finance Committee conducted a hearing about health care costs and coverage. The testimony focused on the following themes:
- Market stabilization per the Affordable Care Act (ACA) and its importance in bringing predictability and stability to the insurance marketplace
- The increasing costs of prescription drugs and the impact they are having on the overall cost of health care with the suggestion that the committee look at the Veterans Health Administration prescription drug model as one that has success in managing costs
- The importance of the continued delivery system reforms such as the increased value of bulk purchasing and the use of tools such as Medicaid managed care to provide care coordination in managing quality and costs
- Providing states with increased flexibility to manage their individual markets through appropriate streamlined waivers
- Greater uses of health savings accounts
- Providing incentives for those in the individual market to have continuous coverage
Senator Bob Casey (D–PA) expressed his optimism that the repeal and replace conversation was shifting to find innovative ways to fix what is not working with the ACA instead of an outright repeal of Medicaid expansion.
Testifying at the hearing were:
- Avik Roy, Co-founder and President, Foundation for Research and Equal Opportunity
- Edmund F. Haislmaier, Senior Research Fellow, The Heritage Foundation
- Andrew M. Slavitt, Former Acting Administrator, Centers for Medicare & Medicaid Services
- Aviva Aron-Dine, PhD, Senior Fellow and Senior Counselor, Center on Budget and Policy Priorities
For more information, contact Laura Stevens Kent, vice president, federal advocacy.